Table 1 Zika virus CD8 peptide selection based on multiparameters using immunoinformatics tools.
From: In silico construction of a multiepitope Zika virus vaccine using immunoinformatics tools
Protein | Epitope0 | Size (aa) | Position | Nº of alleles1 | % of total alleles2 | Immunogenicity score (IEDB)3 | Nº of HLAs w/ Percentile Rank ≤ 204 | Nº of HLAs with SMM IC50 ≤ 500 nM5 | Nº of HLAs with ANN IC50 ≤ 500 nM6 |
---|---|---|---|---|---|---|---|---|---|
Capsid Protein | VSPFGGLKRLP (C_24-34) | 11 | 24–34 | 17 | 42.5 | 0.0036 | 12 | 1 | 1 |
prM Protein | IFRNPGFALAAAAIA (prM_129-143) | 15 | 129–143 | 16 | 34.04 | 0.3976 | 49 | 4 | 8 |
Envelope Protein E | SQEGAVHTALA (E_260-270) | 11 | 260–270 | 10 | 25 | 0.23948 | 15 | 3 | 3 |
Envelope Protein E | VRGAKRMAVLG (E_415-425) | 11 | 415–425 | 10 | 25 | − 0.21504 | 15 | 2 | 1 |
Envelope Protein E | MQTLTPVGRLI (E_349-359) | 11 | 349–359 | 9 | 22.5 | 0.13774 | 26 | 3 | 2 |
NS1 | WRSVEGELNAILEENGVQL (NS1_68-86) | 19 | 68–86 | 11 | 23.40 | 0.5434 | 34 | 3 | 3 |
NS2A | ALIAAFKVR (NS2A_78-86) | 9 | 78–86 | 5 | 10.64 | 0.07299 | 8 | 1 | 1 |
NS2B | SEVLTAVGLICAL (NS2B_5-17) | 13 | 5–17 | 22 | 46.81 | 0.24318 | 40 | 8 | 7 |
NS3 | VREAIKTRLRTVIL (NS3_209-222) | 14 | 209–222 | 14 | 29.79 | 0.26841 | 34 | 6 | 6 |
NS4A | GKMGFGMVTLG (NS4A_79-89) | 11 | 79–89 | 9 | 22.5 | 0.01824 | 24 | 4 | 4 |
NS4A | GAAFGVMEALGT (NS4A_1-12) | 12 | 1–12 | 12 | 30 | 0.17747 | 29 | 4 | 3 |
NS4B | TPLTLIVAI (NS4B_105-113) | 9 | 105–113 | 13 | 27.66 | 0.20764 | 10 | 2 | 1 |
NS5 | YMWLGARFLEFEAL (NS5_477-490) | 14 | 477–490 | 17 | 36.17 | 0.6005 | 54 | 6 | 6 |